Neurological Disorder Diagnostics Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Factors Are Driving the Anticipated Growth Rate of the Neurological Disorder Diagnostics Market Through 2034?
The market size of diagnostics for neurological disorders has witnessed robust growth in the past few years. The value is projected to surge from $11.75 billion in 2024 to $12.61 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.3%. The notable expansion during the historic period can be ascribed to factors such as the escalated occurrence of neurological disorders, increase in the elderly population, heightened focus on early detection and management of diseases, improved understanding of neurological disorders, and a greater emphasis on preemptive diagnosis.
Predictions indicate that the market size for neurological disorder diagnostics will experience significant expansion in the coming years. By 2029, it is projected to increase to a value of $16.6 billion, with a compound annual growth rate (CAGR) of 7.1%. This expected growth in the forecast duration is linked to several factors such as enhanced awareness and education, higher spending on healthcare, bettered healthcare service accessibility, the growth in diagnostic centers, and an observed increase in personalized medicine adoption. Noteworthy trends anticipated in the forecast period encompass progress in neuroimaging techniques, a rise in the usage of wearable devices and technologies for remote monitoring, innovations in biomarker discovery and genetic testing, incorporation of artificial intelligence and machine learning algorithms, and the emergence of point-of-care diagnostic mechanisms.
What External and Internal Drivers Are Contributing to the Growth of the Neurological Disorder Diagnostics Market’s Growth?
The rise in Alzheimer’s disease is anticipated to fuel advancement in the neurological disorder diagnostics market. Alzheimer’s disease is a progressive neurodegenerative disorder marked by a slow deterioration of cognitive abilities, which includes memory, reasoning, and problem-solving. It merges genetic elements, including specific gene mutations and variations, accumulation of amyloid plaques and tau tangles in the brain, unending inflammation, vascular complications, and lifestyle attributes. Diagnostics for neurological disorders aids in combating Alzheimer’s disease through the provision of early and precise detection using advanced imaging, biomarker analysis, and cognitive evaluations. Case in point, in September 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia; in 2023, about 411,100 individuals in Australia existed with dementia, constituting around 257,500 women and 153,700 men. Hence, the escalating prevalence of Alzheimer’s disease is powering the expansion of the neurological disorder diagnostics market.
Get Your Free Sample of the Global Neurological Disorder Diagnostics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp
Who Are the Major Industry Leaders Accelerating Growth in the Neurological Disorder Diagnostics Market?
Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
Which Current Trends Are Having the Most Impact on the Neurological Disorder Diagnostics Market?
Leading firms in the neurological disorder diagnostics market are concentrating on the creation of innovative solutions, such as neurological disease quantification software, to assist the one billion people globally affected by neurological disorders. This type of software serves as an instrumental tool in recording and assessing the brain’s function and progression of neurological conditions. For example, in January 2024, Quibim, a biotechnology firm based in Spain, unveiled QP-Brain, a software utilizing artificial intelligence in the early diagnosis of neurological diseases. Quibim’s QP-Brain is an advanced neuroimaging analysis software that is designed to quantify alterations in brain tissue in the context of neurological disorders. It comes with distinct features such as AI-driven automatic segmentation and comprehensive volumetric analysis, providing accurate insight into changes in the brain’s structure for clinical and research-based uses.
Get Instant Access to the Global Neurological Disorder Diagnostics Market Report with Swift Delivery!
Which Key Segments Define the Structure of the Neurological Disorder Diagnostics Market and Their Growth Potential?
The neurological disorder diagnosticsmarket covered in this report is segmented –
1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
Which Regions Are Key Players in the Growth of the Neurological Disorder Diagnostics Market?
North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Elements Shape the Definition of the Neurological Disorder Diagnostics Market?
Neurological disorder diagnostics refer to the various methods and technologies used to identify, assess, and monitor diseases affecting the nervous system, including the brain, spinal cord, and nerves. These diagnostics involve advanced imaging techniques, biomarker analysis, genetic testing, and cognitive assessments to detect abnormalities, determine disease presence and progression, and guide treatment strategies for neurological conditions.
Browse Through More Similar Reports By The Business Research Company:
Diabetic Neuropathy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
Intraoperative Neuromonitoring Global Market Report 2024
Interventional Neurology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
